InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the detailed record of transactions filed by DANTZKER DAVID, Director. Director active across 2 companies, notably SURMODICS INC. Aggregated, 11 disclosures have been logged. Total volume traded: €291k. The latest transaction was filed on 10 February 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations11 total
01,375 shares0
Common Stock
SEC:0001209191-22-009306:0·
€16,539389 shares@ €42.51655.6% of flow
Common Stock
SEC:0001209191-22-000737·
€16,539389 shares@ €42.51655.6% of flow
Common Stock
SEC:0001209191-22-000737:0·
€145,2743,475 shares@ €41.805549.0% of flow
Common Stock
SEC:0001209191-21-066991·
€145,2743,475 shares@ €41.805549.0% of flow
Common Stock
SEC:0001209191-21-066991:0·
€102,6175,576 shares@ €18.403334.6% of flow
Common Stock
SEC:0001209191-21-063306·
€102,6175,576 shares@ €18.403334.6% of flow
Common Stock
SEC:0001209191-21-063306:0·
€16,188337 shares@ €48.03675.5% of flow
Common Stock
SEC:0001209191-21-058941·
€16,188337 shares@ €48.03675.5% of flow
Common Stock
SEC:0001209191-21-058941:0·
€15,785345 shares@ €45.75445.3% of flow
Common Stock
SEC:0001209191-21-044723·
€15,785345 shares@ €45.75445.3% of flow
Common Stock
SEC:0001209191-21-044723:0·
11 of 11 declarations
About DANTZKER DAVID
David Dantzker is a Director of Surmodics Inc. In this role, he contributes to the strategic direction of the company and oversight of its operations. His expertise in the medical device sector is essential for guiding Surmodics towards its performance and innovation objectives. He is committed to ensuring good governance and accountability within the board.
